Literature DB >> 9237051

Neurochemical actions of gabapentin in mouse brain.

J P Leach1, G J Sills, E Butler, G Forrest, G G Thompson, M J Brodie.   

Abstract

Gabapentin (GBP) is a recently licensed antiepileptic, drug whose mode of action remains to be fully elucidated. The following studies were designed to investigate the effects of GBP on several gamma-aminobutyric acid (GABA) related neurochemical parameters in mouse brain. GBP (0-75 mg/kg) was administered by intraperitoneal injection either as a single dose or twice daily for 8 days. Animals were sacrificed 4 h after the final administration and their brains removed and analysed for concentrations of GABA, glutamate and glutamine and the activities of GABA-transaminase (GABA-T) and glutamic acid decarboxylase (GAD). Single dose GBP increased brain GABA-T activity and glutamine concentration but was without effect on GAD activity or the concentrations of GABA and glutamate. Following repeated treatment with GBP, brain GABA-T activity was consistently decreased and there was also a decrease in brain glutamate concentration. Repeated drug treatment was without effect on the activity of GAD or on the concentrations of GABA and glutamine. These results suggest that GBP has effects on the GABAergic system which may contribute to its antiepileptic and/or neuroprotective actions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237051     DOI: 10.1016/s0920-1211(97)01034-6

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  9 in total

Review 1.  Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.

Authors:  Bankole A Johnson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  Novel approaches to the treatment of cocaine addiction.

Authors:  Mehmet Sofuoglu; Thomas R Kosten
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Isobolographic characterisation of interactions among selected newer antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model.

Authors:  Jarogniew J Luszczki; Stanislaw J Czuczwar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-08-23       Impact factor: 3.000

4.  The impact of gabapentin administration on brain GABA and glutamate concentrations: a 7T ¹H-MRS study.

Authors:  Kejia Cai; Ravi Pr Nanga; Lisa Lamprou; Claudia Schinstine; Mark Elliott; Hari Hariharan; Ravinder Reddy; C Neill Epperson
Journal:  Neuropsychopharmacology       Date:  2012-08-08       Impact factor: 7.853

5.  Effects of antiepileptic drugs on GABA release from rat and human neocortical synaptosomes.

Authors:  M Kammerer; M P Rassner; T M Freiman; T J Feuerstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-05-02       Impact factor: 3.000

6.  VEP indices of cortical lateral interactions in epilepsy treatment.

Authors:  Mary M Conte; Jonathan D Victor
Journal:  Vision Res       Date:  2008-06-24       Impact factor: 1.886

7.  Isobolographic profile of interactions between tiagabine and gabapentin: a preclinical study.

Authors:  Jarogniew J Luszczki; Stanislaw J Czuczwar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-19       Impact factor: 3.000

8.  Brain GABA and Glutamate Concentrations Following Chronic Gabapentin Administration: A Convenience Sample Studied During Early Abstinence From Alcohol.

Authors:  Dieter J Meyerhoff; Donna E Murray; Timothy C Durazzo; David L Pennington
Journal:  Front Psychiatry       Date:  2018-03-15       Impact factor: 4.157

9.  Subchronic treatment with antiepileptic drugs modifies pentylenetetrazol-induced seizures in mice: Its correlation with benzodiazepine receptor binding.

Authors:  Luisa Rocha
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.